The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Generic Injectable Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Generic Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Generic Injectable Drugs market size is estimated to be worth US$ 31500 million in 2021 and is forecast to a readjusted size of USD 39670 million by 2028 with a CAGR of 3.3% during review period. Oncology accounting for % of the Generic Injectable Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Small Molecule segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Generic Injectable Drugs include Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, and Dr. Reddy’s Laboratories Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Generic Injectable Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Small Molecule
Large Molecule
Market segment by Application, can be divided into
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Market segment by players, this report covers
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Generic Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Generic Injectable Drugs, with revenue, gross margin and global market share of Generic Injectable Drugs from 2019 to 2022.
Chapter 3, the Generic Injectable Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Generic Injectable Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Generic Injectable Drugs research findings and conclusion, appendix and data source.
Geographical Area
Global
The Generic Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Generic Injectable Drugs market size is estimated to be worth US$ 31500 million in 2021 and is forecast to a readjusted size of USD 39670 million by 2028 with a CAGR of 3.3% during review period. Oncology accounting for % of the Generic Injectable Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Small Molecule segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Generic Injectable Drugs include Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, and Dr. Reddy’s Laboratories Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Generic Injectable Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Small Molecule
Large Molecule
Market segment by Application, can be divided into
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Market segment by players, this report covers
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Generic Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Generic Injectable Drugs, with revenue, gross margin and global market share of Generic Injectable Drugs from 2019 to 2022.
Chapter 3, the Generic Injectable Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Generic Injectable Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Generic Injectable Drugs research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Generic Injectable Drugs
1.2 Classification of Generic Injectable Drugs by Type
1.2.1 Overview: Global Generic Injectable Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Generic Injectable Drugs Revenue Market Share by Type in 2021
1.2.3 Small Molecule
1.2.4 Large Molecule
1.3 Global Generic Injectable Drugs Market by Application
1.3.1 Overview: Global Generic Injectable Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Global Generic Injectable Drugs Market Size & Forecast
1.5 Global Generic Injectable Drugs Market Size and Forecast by Region
1.5.1 Global Generic Injectable Drugs Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Generic Injectable Drugs Market Size by Region, (2017-2022)
1.5.3 North America Generic Injectable Drugs Market Size and Prospect (2017-2028)
1.5.4 Europe Generic Injectable Drugs Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Generic Injectable Drugs Market Size and Prospect (2017-2028)
1.5.6 South America Generic Injectable Drugs Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Generic Injectable Drugs Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Generic Injectable Drugs Market Drivers
1.6.2 Generic Injectable Drugs Market Restraints
1.6.3 Generic Injectable Drugs Trends Analysis
2 Company Profiles
2.1 Hospira (Pfizer Inc.)
2.1.1 Hospira (Pfizer Inc.) Details
2.1.2 Hospira (Pfizer Inc.) Major Business
2.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Product and Solutions
2.1.4 Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Hospira (Pfizer Inc.) Recent Developments and Future Plans
2.2 Fresenius Kabi
2.2.1 Fresenius Kabi Details
2.2.2 Fresenius Kabi Major Business
2.2.3 Fresenius Kabi Generic Injectable Drugs Product and Solutions
2.2.4 Fresenius Kabi Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Fresenius Kabi Recent Developments and Future Plans
2.3 Sandoz (Novartis)
2.3.1 Sandoz (Novartis) Details
2.3.2 Sandoz (Novartis) Major Business
2.3.3 Sandoz (Novartis) Generic Injectable Drugs Product and Solutions
2.3.4 Sandoz (Novartis) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Sandoz (Novartis) Recent Developments and Future Plans
2.4 Hikma Pharmaceuticals PLC
2.4.1 Hikma Pharmaceuticals PLC Details
2.4.2 Hikma Pharmaceuticals PLC Major Business
2.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product and Solutions
2.4.4 Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Hikma Pharmaceuticals PLC Recent Developments and Future Plans
2.5 Dr. Reddy’s Laboratories Ltd
2.5.1 Dr. Reddy’s Laboratories Ltd Details
2.5.2 Dr. Reddy’s Laboratories Ltd Major Business
2.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product and Solutions
2.5.4 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
2.6 Grifols
2.6.1 Grifols Details
2.6.2 Grifols Major Business
2.6.3 Grifols Generic Injectable Drugs Product and Solutions
2.6.4 Grifols Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Grifols Recent Developments and Future Plans
2.7 Nichi-Iko Group (Sagent)
2.7.1 Nichi-Iko Group (Sagent) Details
2.7.2 Nichi-Iko Group (Sagent) Major Business
2.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product and Solutions
2.7.4 Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Nichi-Iko Group (Sagent) Recent Developments and Future Plans
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Generic Injectable Drugs Product and Solutions
2.8.4 Teva Pharmaceutical Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Teva Pharmaceutical Recent Developments and Future Plans
2.9 Auromedics
2.9.1 Auromedics Details
2.9.2 Auromedics Major Business
2.9.3 Auromedics Generic Injectable Drugs Product and Solutions
2.9.4 Auromedics Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Auromedics Recent Developments and Future Plans
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Generic Injectable Drugs Product and Solutions
2.10.4 Sanofi Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sanofi Recent Developments and Future Plans
2.11 Gland Pharma
2.11.1 Gland Pharma Details
2.11.2 Gland Pharma Major Business
2.11.3 Gland Pharma Generic Injectable Drugs Product and Solutions
2.11.4 Gland Pharma Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Gland Pharma Recent Developments and Future Plans
2.12 Endo International PLC
2.12.1 Endo International PLC Details
2.12.2 Endo International PLC Major Business
2.12.3 Endo International PLC Generic Injectable Drugs Product and Solutions
2.12.4 Endo International PLC Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Endo International PLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Generic Injectable Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Generic Injectable Drugs Players Market Share in 2021
3.2.2 Top 10 Generic Injectable Drugs Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Generic Injectable Drugs Players Head Office, Products and Services Provided
3.4 Generic Injectable Drugs Mergers & Acquisitions
3.5 Generic Injectable Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Generic Injectable Drugs Revenue and Market Share by Type (2017-2022)
4.2 Global Generic Injectable Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Generic Injectable Drugs Revenue Market Share by Application (2017-2022)
5.2 Global Generic Injectable Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Generic Injectable Drugs Revenue by Type (2017-2028)
6.2 North America Generic Injectable Drugs Revenue by Application (2017-2028)
6.3 North America Generic Injectable Drugs Market Size by Country
6.3.1 North America Generic Injectable Drugs Revenue by Country (2017-2028)
6.3.2 United States Generic Injectable Drugs Market Size and Forecast (2017-2028)
6.3.3 Canada Generic Injectable Drugs Market Size and Forecast (2017-2028)
6.3.4 Mexico Generic Injectable Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Generic Injectable Drugs Revenue by Type (2017-2028)
7.2 Europe Generic Injectable Drugs Revenue by Application (2017-2028)
7.3 Europe Generic Injectable Drugs Market Size by Country
7.3.1 Europe Generic Injectable Drugs Revenue by Country (2017-2028)
7.3.2 Germany Generic Injectable Drugs Market Size and Forecast (2017-2028)
7.3.3 France Generic Injectable Drugs Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Generic Injectable Drugs Market Size and Forecast (2017-2028)
7.3.5 Russia Generic Injectable Drugs Market Size and Forecast (2017-2028)
7.3.6 Italy Generic Injectable Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Generic Injectable Drugs Revenue by Type (2017-2028)
8.2 Asia-Pacific Generic Injectable Drugs Revenue by Application (2017-2028)
8.3 Asia-Pacific Generic Injectable Drugs Market Size by Region
8.3.1 Asia-Pacific Generic Injectable Drugs Revenue by Region (2017-2028)
8.3.2 China Generic Injectable Drugs Market Size and Forecast (2017-2028)
8.3.3 Japan Generic Injectable Drugs Market Size and Forecast (2017-2028)
8.3.4 South Korea Generic Injectable Drugs Market Size and Forecast (2017-2028)
8.3.5 India Generic Injectable Drugs Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Generic Injectable Drugs Market Size and Forecast (2017-2028)
8.3.7 Australia Generic Injectable Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Generic Injectable Drugs Revenue by Type (2017-2028)
9.2 South America Generic Injectable Drugs Revenue by Application (2017-2028)
9.3 South America Generic Injectable Drugs Market Size by Country
9.3.1 South America Generic Injectable Drugs Revenue by Country (2017-2028)
9.3.2 Brazil Generic Injectable Drugs Market Size and Forecast (2017-2028)
9.3.3 Argentina Generic Injectable Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Generic Injectable Drugs Revenue by Type (2017-2028)
10.2 Middle East & Africa Generic Injectable Drugs Revenue by Application (2017-2028)
10.3 Middle East & Africa Generic Injectable Drugs Market Size by Country
10.3.1 Middle East & Africa Generic Injectable Drugs Revenue by Country (2017-2028)
10.3.2 Turkey Generic Injectable Drugs Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Generic Injectable Drugs Market Size and Forecast (2017-2028)
10.3.4 UAE Generic Injectable Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Generic Injectable Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Generic Injectable Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Generic Injectable Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Generic Injectable Drugs Revenue (USD Million) by Region (2017-2022)
Table 5. Global Generic Injectable Drugs Revenue Market Share by Region (2023-2028)
Table 6. Hospira (Pfizer Inc.) Corporate Information, Head Office, and Major Competitors
Table 7. Hospira (Pfizer Inc.) Major Business
Table 8. Hospira (Pfizer Inc.) Generic Injectable Drugs Product and Solutions
Table 9. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 11. Fresenius Kabi Major Business
Table 12. Fresenius Kabi Generic Injectable Drugs Product and Solutions
Table 13. Fresenius Kabi Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Sandoz (Novartis) Corporate Information, Head Office, and Major Competitors
Table 15. Sandoz (Novartis) Major Business
Table 16. Sandoz (Novartis) Generic Injectable Drugs Product and Solutions
Table 17. Sandoz (Novartis) Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Hikma Pharmaceuticals PLC Corporate Information, Head Office, and Major Competitors
Table 19. Hikma Pharmaceuticals PLC Major Business
Table 20. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product and Solutions
Table 21. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Dr. Reddy’s Laboratories Ltd Corporate Information, Head Office, and Major Competitors
Table 23. Dr. Reddy’s Laboratories Ltd Major Business
Table 24. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product and Solutions
Table 25. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Grifols Corporate Information, Head Office, and Major Competitors
Table 27. Grifols Major Business
Table 28. Grifols Generic Injectable Drugs Product and Solutions
Table 29. Grifols Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Nichi-Iko Group (Sagent) Corporate Information, Head Office, and Major Competitors
Table 31. Nichi-Iko Group (Sagent) Major Business
Table 32. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product and Solutions
Table 33. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Teva Pharmaceutical Major Business
Table 36. Teva Pharmaceutical Generic Injectable Drugs Product and Solutions
Table 37. Teva Pharmaceutical Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Auromedics Corporate Information, Head Office, and Major Competitors
Table 39. Auromedics Major Business
Table 40. Auromedics Generic Injectable Drugs Product and Solutions
Table 41. Auromedics Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sanofi Corporate Information, Head Office, and Major Competitors
Table 43. Sanofi Major Business
Table 44. Sanofi Generic Injectable Drugs Product and Solutions
Table 45. Sanofi Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Gland Pharma Corporate Information, Head Office, and Major Competitors
Table 47. Gland Pharma Major Business
Table 48. Gland Pharma Generic Injectable Drugs Product and Solutions
Table 49. Gland Pharma Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Endo International PLC Corporate Information, Head Office, and Major Competitors
Table 51. Endo International PLC Major Business
Table 52. Endo International PLC Generic Injectable Drugs Product and Solutions
Table 53. Endo International PLC Generic Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Generic Injectable Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Generic Injectable Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Generic Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Generic Injectable Drugs Players Head Office, Products and Services Provided
Table 58. Generic Injectable Drugs Mergers & Acquisitions in the Past Five Years
Table 59. Generic Injectable Drugs New Entrants and Expansion Plans
Table 60. Global Generic Injectable Drugs Revenue (USD Million) by Type (2017-2022)
Table 61. Global Generic Injectable Drugs Revenue Share by Type (2017-2022)
Table 62. Global Generic Injectable Drugs Revenue Forecast by Type (2023-2028)
Table 63. Global Generic Injectable Drugs Revenue by Application (2017-2022)
Table 64. Global Generic Injectable Drugs Revenue Forecast by Application (2023-2028)
Table 65. North America Generic Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Generic Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Generic Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Generic Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Generic Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Generic Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Generic Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Generic Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Generic Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Generic Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Generic Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Generic Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Generic Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Generic Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Generic Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Generic Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Generic Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Generic Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Generic Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Generic Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Generic Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Generic Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Generic Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Generic Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Generic Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Generic Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Generic Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Generic Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Generic Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Generic Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Generic Injectable Drugs Picture
Figure 2. Global Generic Injectable Drugs Revenue Market Share by Type in 2021
Figure 3. Small Molecule
Figure 4. Large Molecule
Figure 5. Generic Injectable Drugs Revenue Market Share by Application in 2021
Figure 6. Oncology Picture
Figure 7. Anesthesia Picture
Figure 8. Anti-Infectives Picture
Figure 9. Parenteral Nutrition Picture
Figure 10. Cardiovascular Diseases Picture
Figure 11. Global Generic Injectable Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Generic Injectable Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Generic Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 14. Global Generic Injectable Drugs Revenue Market Share by Region in 2021
Figure 15. North America Generic Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Generic Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Generic Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Generic Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Generic Injectable Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Generic Injectable Drugs Market Drivers
Figure 21. Generic Injectable Drugs Market Restraints
Figure 22. Generic Injectable Drugs Market Trends
Figure 23. Hospira (Pfizer Inc.) Recent Developments and Future Plans
Figure 24. Fresenius Kabi Recent Developments and Future Plans
Figure 25. Sandoz (Novartis) Recent Developments and Future Plans
Figure 26. Hikma Pharmaceuticals PLC Recent Developments and Future Plans
Figure 27. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
Figure 28. Grifols Recent Developments and Future Plans
Figure 29. Nichi-Iko Group (Sagent) Recent Developments and Future Plans
Figure 30. Teva Pharmaceutical Recent Developments and Future Plans
Figure 31. Auromedics Recent Developments and Future Plans
Figure 32. Sanofi Recent Developments and Future Plans
Figure 33. Gland Pharma Recent Developments and Future Plans
Figure 34. Endo International PLC Recent Developments and Future Plans
Figure 35. Global Generic Injectable Drugs Revenue Share by Players in 2021
Figure 36. Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Generic Injectable Drugs Revenue Market Share in 2021
Figure 38. Global Top 10 Players Generic Injectable Drugs Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Generic Injectable Drugs Revenue Share by Type in 2021
Figure 41. Global Generic Injectable Drugs Market Share Forecast by Type (2023-2028)
Figure 42. Global Generic Injectable Drugs Revenue Share by Application in 2021
Figure 43. Global Generic Injectable Drugs Market Share Forecast by Application (2023-2028)
Figure 44. North America Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 45. North America Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 46. North America Generic Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Generic Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 53. Germany Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Generic Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 61. China Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 68. South America Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 69. South America Generic Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Generic Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
